What is the ticker symbol for Kymera Therapeutics?

Kymera Therapeutics trades under the ticker KYMR on NASDAQ.

What sector does Kymera Therapeutics operate in?

Kymera Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze KYMR in a portfolio?

PortView shows KYMR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Kymera Therapeutics (KYMR) Stock Analysis

NASDAQHealthcareBiotechnology

$119.20+0.12%

1-year price historyRange $42.20 – $127.31

52-week range$119.20

$40.10$130.05

What Kymera Therapeutics does

Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.

Key metrics

Market cap

$9.80B

P/E (TTM)

-37.25

EPS (TTM)

$-3.20

Beta

1.95

Dividend yield

0.00%

Revenue / share

$1.07

50-day avg

$113.28

200-day avg

$88.29

52-week high

$130.05

52-week low

$40.10

CEO

Nello Mainolfi

ETFs linked to KYMR

Broad-market and Healthcare sector ETFs an investor holding Kymera Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how KYMR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze KYMR in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Kymera Therapeutics?: Kymera Therapeutics trades under the ticker KYMR on NASDAQ.
Which exchange is KYMR listed on?: KYMR is listed on NASDAQ.
What sector does Kymera Therapeutics operate in?: Kymera Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze KYMR in a portfolio?: PortView shows KYMR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.